Medicine made by MegaPro Biomedical performs new breakthrough for the benefit of patients with chronic kidney disease
|
2019-05-27 |
MegaPro Biomedical, Co. wins the "15th National Innovation Award-Enterprise Innovation Award"
|
2019-03-07 |
MegaPro Biomedical was invited to “The Third China BioMed Innovation and Investment Conference” hosted by PhIRDA
|
2018-09-14 |
MegaPro Biomedical was invited to participate in the "3rd China Pharmaceutical Innovation and Investment Conference" hosted by China Pharmaceutical industry Research and Development Association
|
2018-09-14 |
Outstanding performance from MegaPro Biomedical, the contrast agent has received approval by FDA for Phase II of clinical trial
|
2018-02-09 |
MegaPro Biomedical has performed brilliantly, and the rapid development process of the developer product has been approved by the US FDA to enter the clinical phase II trial
|
2018-02-09 |
Global Bio & Investment Interview with Dr. Jassy Wang, General Manager of MegaPro Biomedical
|
2017-10-05 |
2017 Taiwan Biotechnology Industry Future Summit
|
2017-08-01 |
Interview with Focus Reports
|
2017-06-15 |
MegaPro Biomedical Wins the 13th National Innovation Award - Startup Award
|
2017-01-12 |